Fig. 1.
Fig. 1. Probability of event-free survival among patients achieving CR following treatment with IA, FA, or TA regimens. / Kaplan-Meier estimates of the proportion of patients achieving CR who have neither relapsed nor died in CR dated from CR date. Log-rankP value < .001. Events have occurred in 191 of the 248 IA CRs, 279 of the 330 FA CRs, and 144 of the 211 TA CRs. Median censoring times (in weeks) are 238 (IA), 206 (FA), and 56 (TA).

Probability of event-free survival among patients achieving CR following treatment with IA, FA, or TA regimens.

Kaplan-Meier estimates of the proportion of patients achieving CR who have neither relapsed nor died in CR dated from CR date. Log-rankP value < .001. Events have occurred in 191 of the 248 IA CRs, 279 of the 330 FA CRs, and 144 of the 211 TA CRs. Median censoring times (in weeks) are 238 (IA), 206 (FA), and 56 (TA).

Close Modal

or Create an Account

Close Modal
Close Modal